Abstract
In October 2012, a maternal pertussis vaccination program was implemented in England following an increased incidence and mortality in infants. We evaluated the cost-effectiveness of the program by comparing pertussis-related infant hospitalizations and deaths in 2012-2017 with nonvaccination scenarios. Despite considerable uncertainties, findings support the cost-effectiveness of the program.
Original language | English (US) |
---|---|
Pages (from-to) | 1984-1987 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 71 |
Issue number | 8 |
DOIs | |
State | Published - Oct 15 2020 |
Keywords
- economic evaluation
- maternal pertussis vaccination
- pertussis vaccine
- postimplementation
- whooping cough
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases